Natural Alternatives International (NAII) Peer Comparison

$2.08

$-0.04 (-1.89%)

As on 04-Sep-2026 16:00EDT

Market cap

$13 Mln

Revenue (TTM)

$141 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Edit

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Market cap ($ Mln)	13	14,631	12,066	12,237	10,826
Revenue ($ Mln)	141	692	831	5,020	777
Net Profit ($ Mln)	-14.37	-696.24	54.90	-199.00	-191.64
Net Margin (%)	-10.19	-100.64	6.61	-3.96	-24.68
RoE (%)	-21.75	--	8.11	-3.03	-223.36
Price to Earnings	--	--	248.04	--	--
Price-To-Book	0.21	123.68	17.29	1.86	131.04

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Operating Revenue	140.99	691.84	830.81	5,020.00	776.57
Cost of Revenue	131.07	47.45	14.09	2,380.00	52.53
Gross Profit	9.29	473.81	748.43	2,050.00	591.02
Operating Expenses	18.03	1,187.86	810.32	2,178.00	912.58
Operating Profit (EBIT)	-8.10	-543.47	6.41	462.00	-188.54
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-9.59	-706.17	26.37	-166.00	-191.09
Provision for Tax	4.78	-7.73	-35.26	33.00	0.56
Profit after Tax (Net Income)	-14.37	-696.24	54.90	-199.00	-191.64
Minority Interest	0.00	10.15	0.00	0.00	0.00
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Shareholder's Funds	63.11	-2,515.22	705.78	6,588.00	83.30
Minority Interest	0.00	10.15	0.00	0.00	0.00
Non-Current Liabilities	52.65	2,832.54	29.12	5,121.00	217.70
Current Liabilities	39.13	890.65	153.80	1,852.00	460.45
Total Liabilities	151.94	936.03	836.65	13,358.00	689.81

Assets ($ Mln)

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Non-Current Assets	90.89	124.16	449.03	9,764.00	104.88
Current Assets	64.00	1,093.14	439.68	3,797.00	656.57
Total Assets	151.94	936.03	836.65	13,358.00	689.81
Total Debt*	65.17	2,493.78	9.42	3,918.00	219.21
Net Current Assets	24.87	202.49	285.87	1,945.00	196.12

Cashflow ($ Mln)

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Cash From Operating Activities	5.93	-445.91	142.00	560.00	-93.41
Cash Flow from Investing Activities	-3.61	-24.49	69.76	-279.00	-0.48
Cash from Financing Activities	-1.97	359.29	-220.37	-275.00	101.47
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
ROCE (%)	-10.04	-159.44	14.87	-2.21	-63.21
ROE (%)	-21.75	41.15	8.11	-3.03	-223.36
ROA (%)	-7.72	-41.39	5.52	-1.30	-17.39
EBIT Margin (%)	-4.68	-89.09	3.17	1.61	-17.57
Net Margin (%)	-10.19	-100.64	6.61	-3.96	-24.68
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Revenue Growth (%)	12.36	193.38	16.02	11.95	56.87
EBIT Growth (%)	33.22	5.05	-79.11	-90.61	42.45
Net Profit Growth (%)	-74.55	10.33	-58.66	-145.85	22.38
EPS Growth (%)	-69.62	12.58	-62.44	-146.42	25.75
Book Value Growth (%)	-18.76	-36.90	12.98	-3.87	9.44

Valuation Ratios

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Price / Earnings	-1.49	-20.69	41.86	-48.47	-50.48
Price / Book Value	0.21	123.68	17.29	1.86	131.04
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	-31.40	-27.82	406.40	20.30	-59.76
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Debt to Equity	0.13	-0.77	0.00	0.58	1.42
Short term debt to equity ratio	0.20	-0.22	0.00	0.01	0.85
Current Ratio	1.64	1.23	2.86	2.05	1.43
Quick Ratio	0.87	1.17	2.77	1.10	1.34
Interest Coverage	-9.29	-6.86	--	0.36	-37.09

Operating Efficiency Ratios

	Natural Alternatives International (NAII)	BridgeBio Pharma (BBIO)	Corcept Therapeutics (CORT)	Elanco Animal Health (ELAN)	Axsome Therapeutics (AXSM)
Debtors to sales (%)	14.60	36.78	9.26	22.95	35.73
Asset Turnover	0.76	0.41	0.84	0.33	0.70
Receivable days	44.74	52.44	28.27	70.73	104.82
Inventory Days	74.40	172.81	355.76	226.89	167.98
Payable days	42.55	296.14	785.55	45.50	529.03
Cash Conversion Cycle	76.59	-70.89	-401.52	252.12	-256.23

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly